Standard Chem & Pharm CO., LTD. (1720.TW)
TWD 58.7
(-0.51%)
TWD 58.7
(-0.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.72 Billion TWD | 9.56% |
| 2022 | 2.48 Billion TWD | 20.3% |
| 2021 | 2.06 Billion TWD | 7.71% |
| 2020 | 1.91 Billion TWD | 12.33% |
| 2019 | 1.7 Billion TWD | 10.65% |
| 2018 | 1.54 Billion TWD | -11.69% |
| 2017 | 1.74 Billion TWD | 10.96% |
| 2016 | 1.57 Billion TWD | 5.43% |
| 2015 | 1.49 Billion TWD | 3.27% |
| 2014 | 1.44 Billion TWD | 11.57% |
| 2013 | 1.29 Billion TWD | -1.31% |
| 2012 | 1.31 Billion TWD | -1.31% |
| 2011 | 1.33 Billion TWD | 8.31% |
| 2010 | 1.23 Billion TWD | 17.23% |
| 2009 | 1.04 Billion TWD | -1.3% |
| 2008 | 1.06 Billion TWD | 3.45% |
| 2007 | 1.02 Billion TWD | 1.62% |
| 2006 | 1.01 Billion TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 715.34 Million TWD | 6.98% |
| 2024 Q2 | 765.35 Million TWD | 6.99% |
| 2023 Q4 | 668.69 Million TWD | -5.2% |
| 2023 Q2 | 648.4 Million TWD | -4.86% |
| 2023 Q1 | 681.51 Million TWD | -0.03% |
| 2023 Q3 | 705.37 Million TWD | 8.79% |
| 2023 FY | 2.64 Billion TWD | 6.33% |
| 2022 Q4 | 681.72 Million TWD | 4.7% |
| 2022 FY | 2.48 Billion TWD | 20.3% |
| 2022 Q3 | 651.14 Million TWD | 2.36% |
| 2022 Q2 | 636.12 Million TWD | 22.66% |
| 2022 Q1 | 518.61 Million TWD | -4.21% |
| 2021 Q3 | 518.67 Million TWD | 1.14% |
| 2021 Q4 | 541.41 Million TWD | 4.38% |
| 2021 Q1 | 494.94 Million TWD | -2.16% |
| 2021 FY | 2.06 Billion TWD | 7.71% |
| 2021 Q2 | 512.83 Million TWD | 3.62% |
| 2020 Q1 | 454.12 Million TWD | -0.48% |
| 2020 Q4 | 505.89 Million TWD | 9.47% |
| 2020 Q3 | 462.12 Million TWD | -7.15% |
| 2020 FY | 1.91 Billion TWD | 12.33% |
| 2020 Q2 | 497.69 Million TWD | 9.59% |
| 2019 Q2 | 449.78 Million TWD | 33.39% |
| 2019 FY | 1.7 Billion TWD | 10.65% |
| 2019 Q4 | 456.29 Million TWD | -2.05% |
| 2019 Q3 | 465.84 Million TWD | 3.57% |
| 2019 Q1 | 337.2 Million TWD | -20.32% |
| 2018 FY | 1.54 Billion TWD | -11.69% |
| 2018 Q4 | 423.22 Million TWD | 4.16% |
| 2018 Q3 | 406.32 Million TWD | 6.95% |
| 2018 Q2 | 379.92 Million TWD | 13.36% |
| 2018 Q1 | 335.14 Million TWD | -17.4% |
| 2017 FY | 1.74 Billion TWD | 10.96% |
| 2017 Q1 | 413.42 Million TWD | 4.45% |
| 2017 Q4 | 405.73 Million TWD | -19.5% |
| 2017 Q3 | 504.02 Million TWD | 18.36% |
| 2017 Q2 | 425.82 Million TWD | 3.0% |
| 2016 Q2 | 408.11 Million TWD | 10.57% |
| 2016 FY | 1.57 Billion TWD | 5.43% |
| 2016 Q1 | 369.1 Million TWD | -5.57% |
| 2016 Q4 | 395.82 Million TWD | -1.83% |
| 2016 Q3 | 403.21 Million TWD | -1.2% |
| 2015 FY | 1.49 Billion TWD | 3.27% |
| 2015 Q4 | 390.86 Million TWD | 7.22% |
| 2015 Q3 | 364.56 Million TWD | 3.36% |
| 2015 Q2 | 352.71 Million TWD | -8.84% |
| 2015 Q1 | 386.93 Million TWD | -0.09% |
| 2014 Q4 | 387.27 Million TWD | 11.14% |
| 2014 FY | 1.44 Billion TWD | 11.57% |
| 2014 Q1 | 350.61 Million TWD | 6.89% |
| 2014 Q2 | 361.33 Million TWD | 3.06% |
| 2014 Q3 | 348.46 Million TWD | -3.56% |
| 2013 Q4 | 328 Million TWD | 10.19% |
| 2013 FY | 1.29 Billion TWD | -1.31% |
| 2013 Q3 | 297.68 Million TWD | -8.38% |
| 2013 Q1 | 347.01 Million TWD | -5.04% |
| 2013 Q2 | 324.89 Million TWD | -6.37% |
| 2012 Q3 | 316.32 Million TWD | -3.7% |
| 2012 Q4 | 365.45 Million TWD | 15.53% |
| 2012 Q2 | 328.48 Million TWD | 7.36% |
| 2012 FY | 1.31 Billion TWD | -1.31% |
| 2012 Q1 | 305.96 Million TWD | -15.11% |
| 2011 Q3 | 316.25 Million TWD | -4.54% |
| 2011 Q4 | 360.44 Million TWD | 13.97% |
| 2011 FY | 1.33 Billion TWD | 8.31% |
| 2011 Q1 | 324.24 Million TWD | -20.82% |
| 2011 Q2 | 331.3 Million TWD | 2.18% |
| 2010 Q1 | 255.57 Million TWD | 0.0% |
| 2010 FY | 1.23 Billion TWD | 17.23% |
| 2010 Q4 | 409.48 Million TWD | 45.41% |
| 2010 Q3 | 281.6 Million TWD | -0.61% |
| 2010 Q2 | 283.33 Million TWD | 10.86% |
| 2009 FY | 1.04 Billion TWD | -1.3% |
| 2008 FY | 1.06 Billion TWD | 3.45% |
| 2007 FY | 1.02 Billion TWD | 1.62% |
| 2006 FY | 1.01 Billion TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Grape King Bio Ltd | 8.53 Billion TWD | 68.063% |
| Maywufa Company Ltd. | 854.37 Million TWD | -218.992% |
| ScinoPharm Taiwan, Ltd. | 1.21 Billion TWD | -124.129% |
| Lotus Pharmaceutical Co., Ltd. | 8.33 Billion TWD | 67.318% |
| LIWANLI Innovation Co., Ltd. | 15.08 Million TWD | -17969.204% |
| YungShin Global Holding Corporation | 2.91 Billion TWD | 6.379% |
| PhytoHealth Corporation | 67.64 Million TWD | -3929.061% |
| SCI Pharmtech, Inc. | 350.32 Million TWD | -677.961% |
| Formosa Laboratories, Inc. | 1.9 Billion TWD | -43.194% |
| PharmaEssentia Corporation | 4.49 Billion TWD | 39.37% |
| Bora Pharmaceuticals Co., LTD. | 6.99 Billion TWD | 61.017% |